AbbVie lifts guidance and dividend; shares gain 1% – Seeking Alpha
AbbVie (ABBV) Q3 results: Revenues: $8,479M (+3.0%); Immunology: $5,041M (-1.6%); Hematologic Oncology: $1,478M (+38.3%); HCV: $698M (-19%).
Net Income: $1,884M (-31.4%); EPS: $1.26 (-30.4%); non-GAAP Net Income: $3,468M (+6.5%); non-GAAP EPS: $2.33 (+8.9%).…
